VRT-043198 is primarily investigated for its potential therapeutic applications in the field of neuroscience. It is being studied as a selective antagonist for specific receptors in the brain, which could play a role in modulating neurological disorders. Researchers are exploring its efficacy in conditions such as anxiety, depression, and neurodegenerative diseases, where receptor dysregulation is a contributing factor. Additionally, its ability to cross the blood-brain barrier makes it a promising candidate for central nervous system-targeted therapies. Preclinical studies are ongoing to evaluate its safety, pharmacokinetics, and potential for clinical use.